Min Li, Xuemin Li, Bin Qiu, Yi Chen, Ping Jiang, Haitao Sun, Yuliang Jiang, Suqing Tian, Kaixian Zhang, Zhe Wang, Ruoyu Wang, Xuequan Huang, Mingwei Huang, Jianguo Zhang, Bin Huo, Xiaodong Huo, Zhe Ji, Junjie Wang
{"title":"Experts consensus on 3D-printing template-assisted CT-guided radioactive iodine-125 seed implantation for recurrent soft tissue carcinoma in China.","authors":"Min Li, Xuemin Li, Bin Qiu, Yi Chen, Ping Jiang, Haitao Sun, Yuliang Jiang, Suqing Tian, Kaixian Zhang, Zhe Wang, Ruoyu Wang, Xuequan Huang, Mingwei Huang, Jianguo Zhang, Bin Huo, Xiaodong Huo, Zhe Ji, Junjie Wang","doi":"10.1007/s10238-025-01575-5","DOIUrl":null,"url":null,"abstract":"<p><p>Permanent radioactive iodine-125 seed implantation (RISI), known as radioactive seed implantation, is a minimally invasive internal radiation technique. This method involves implanting <sup>125</sup>I seeds (4.5 × 0.8 mm, encapsulated in a nickel-titanium alloy) into tumors under image guidance. The radionuclide continuously releases low energy γ-rays, effectively killing tumor cells. RISI delivers high local doses with minimal damage to surrounding normal tissues. It is performed through image-guided percutaneous puncture, accompanied by high precision, minimal trauma, and rapid recovery. In Western countries, RISI is primarily utilized for early-stage prostate cancer. In 2002, Professor Junjie Wang introduced computed tomography (CT)-guided technology for RISI, expanding its indications to head and neck, thoracic, abdominal, pelvic, and spinal tumors. In 2014, he proposed the concept of image-guided interventional brachytherapy, advancing minimally invasive brachytherapy. In 2015, he integrated three-dimensional 3D-printing template (3D-PT) with CT-guided technology, significantly enhancing the precision, quality, and efficiency of RISI, and introduced the concept of stereotactic brachytherapy. Over nearly 20 years, RISI has developed into a standardized procedure, involving preoperative planning, intraoperative optimization, and postoperative verification, highlighting its role in comprehensive cancer treatment. The main treatments for soft tissue sarcoma (STS) include surgery or surgery combined with radiotherapy and chemotherapy. However, STS is prone to local recurrence, and effective treatments are lacking after recurrence. Experts have conducted extensive trials on RISI for the treatment of recurrent STS (r-STS), accumulating significant clinical experience. This study aimed to establish standards and consensus on 3D-PT-assisted CT-guided RISI for the treatment of r-STS.</p>","PeriodicalId":10337,"journal":{"name":"Clinical and Experimental Medicine","volume":"25 1","pages":"52"},"PeriodicalIF":3.2000,"publicationDate":"2025-02-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical and Experimental Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s10238-025-01575-5","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
引用次数: 0
Abstract
Permanent radioactive iodine-125 seed implantation (RISI), known as radioactive seed implantation, is a minimally invasive internal radiation technique. This method involves implanting 125I seeds (4.5 × 0.8 mm, encapsulated in a nickel-titanium alloy) into tumors under image guidance. The radionuclide continuously releases low energy γ-rays, effectively killing tumor cells. RISI delivers high local doses with minimal damage to surrounding normal tissues. It is performed through image-guided percutaneous puncture, accompanied by high precision, minimal trauma, and rapid recovery. In Western countries, RISI is primarily utilized for early-stage prostate cancer. In 2002, Professor Junjie Wang introduced computed tomography (CT)-guided technology for RISI, expanding its indications to head and neck, thoracic, abdominal, pelvic, and spinal tumors. In 2014, he proposed the concept of image-guided interventional brachytherapy, advancing minimally invasive brachytherapy. In 2015, he integrated three-dimensional 3D-printing template (3D-PT) with CT-guided technology, significantly enhancing the precision, quality, and efficiency of RISI, and introduced the concept of stereotactic brachytherapy. Over nearly 20 years, RISI has developed into a standardized procedure, involving preoperative planning, intraoperative optimization, and postoperative verification, highlighting its role in comprehensive cancer treatment. The main treatments for soft tissue sarcoma (STS) include surgery or surgery combined with radiotherapy and chemotherapy. However, STS is prone to local recurrence, and effective treatments are lacking after recurrence. Experts have conducted extensive trials on RISI for the treatment of recurrent STS (r-STS), accumulating significant clinical experience. This study aimed to establish standards and consensus on 3D-PT-assisted CT-guided RISI for the treatment of r-STS.
期刊介绍:
Clinical and Experimental Medicine (CEM) is a multidisciplinary journal that aims to be a forum of scientific excellence and information exchange in relation to the basic and clinical features of the following fields: hematology, onco-hematology, oncology, virology, immunology, and rheumatology. The journal publishes reviews and editorials, experimental and preclinical studies, translational research, prospectively designed clinical trials, and epidemiological studies. Papers containing new clinical or experimental data that are likely to contribute to changes in clinical practice or the way in which a disease is thought about will be given priority due to their immediate importance. Case reports will be accepted on an exceptional basis only, and their submission is discouraged. The major criteria for publication are clarity, scientific soundness, and advances in knowledge. In compliance with the overwhelmingly prevailing request by the international scientific community, and with respect for eco-compatibility issues, CEM is now published exclusively online.